1.
Ludovica pediátr
; 26(2): 46-49, dic.2023.
Artigo
em Espanhol
| LILACS
| ID: biblio-1531142
2.
Farmaco
; 54(8): 517-23, 1999 Aug 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-10510848
RESUMO
A series of diarylsemicarbazones was synthesized and tested against human neoplastic cell lines. The more active members have a l-naphthyl ring at the carbamidic nitrogen, and chloro, dimethylamino or nitro group substituents at the benzylidene moiety. None of these showed affinity to DNA. One of the more active compounds was tested as a topoisomerase I inhibitor and showed a potent effect. SAR studies demonstrated linear correlation between lypophilicity and activity on the most sensitive lines and a definite conformational shape for antineoplastic action.